Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 6 studies | 45% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 4 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| muscle | 100% | 1432238.55 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.23 | 1 / 1 |
| heart | 100% | 181530.36 | 859 / 861 | 0% | 0 | 0 / 0 |
| prostate | 9% | 1885.19 | 23 / 245 | 73% | 44.75 | 364 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 56.08 | 21 / 45 |
| stomach | 20% | 613.27 | 73 / 359 | 26% | 0.71 | 73 / 286 |
| bladder | 0% | 0 | 0 / 21 | 35% | 1.38 | 176 / 504 |
| uterus | 0% | 0 | 0 / 170 | 33% | 64.62 | 150 / 459 |
| lung | 2% | 345.34 | 11 / 578 | 29% | 3.79 | 340 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 0.41 | 9 / 29 |
| intestine | 2% | 70.23 | 16 / 966 | 24% | 0.83 | 124 / 527 |
| ovary | 1% | 29.29 | 2 / 180 | 24% | 0.65 | 102 / 430 |
| esophagus | 2% | 317.91 | 32 / 1445 | 19% | 0.80 | 35 / 183 |
| pancreas | 1% | 24.91 | 3 / 328 | 20% | 0.72 | 35 / 178 |
| skin | 2% | 621.30 | 28 / 1809 | 18% | 0.93 | 86 / 472 |
| breast | 2% | 638.88 | 11 / 459 | 11% | 2.70 | 127 / 1118 |
| brain | 1% | 45.79 | 27 / 2642 | 11% | 0.18 | 77 / 705 |
| thymus | 3% | 419.40 | 19 / 653 | 9% | 3.79 | 53 / 605 |
| peripheral blood | 7% | 2026.29 | 63 / 929 | 0% | 0 | 0 / 0 |
| liver | 1% | 34.22 | 2 / 226 | 4% | 0.19 | 16 / 406 |
| blood vessel | 4% | 1010.42 | 52 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 4% | 0.18 | 35 / 901 |
| adrenal gland | 1% | 33.45 | 2 / 258 | 2% | 0.11 | 5 / 230 |
| adipose | 3% | 229.25 | 33 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 1% | 35.62 | 2 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0046314 | Biological process | phosphocreatine biosynthetic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005829 | Cellular component | cytosol |
| GO_0004111 | Molecular function | creatine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | CKM |
| Protein name | Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK) |
| Synonyms | CKMM |
| Description | FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa. . |
| Accessions | ENST00000221476.4 P06732 |